Articles

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Haematologica Early view Aug 3, 2023 https://doi.org/10.3324/haematol.2023.283245